Lamivudine plus adefovir
Sponsors
Taipei Veterans General Hospital, Taiwan, Keimyung University Dongsan Medical Center, Korea University
Conditions
Chronic Hepatitis B
Phase 4
Switch to Tenofovir Versus Continue Lamivudine/Adefovir Treatment in Lamivudine-resistance Chronic Hepatitis B Patients
NCT01491295
Start: 2012-09-30End: 2019-12-31Target: 160Updated: 2016-04-01
TDF VS LAM + ADV in LAM + ADV Treated LAM-resistant CHB Patients With Undetectable Hepatitis B Virus DNA
CompletedNCT01732367
Start: 2012-11-30End: 2016-04-30Updated: 2016-10-28
Comparison of Telbivudine Plus Adefovir With Lamivudine Plus Adefovir for the Treatment of Lamivudine-resistant Chronic Hepatitis B at 52 Weeks: A Pilot Study
NCT01804387
Start: 2011-05-31End: 2014-05-31Target: 60Updated: 2013-03-05